Status:
COMPLETED
Complete Decongestive Therapy on Head and Neck Lymphedema
Lead Sponsor:
Our Lady of the Lake Hospital
Conditions:
Lymphedema of Face
Secondary Lymphedema
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This will be a prospective, randomized controlled study of \~60 adult patients who have undergone a laryngectomy, neck dissection, maxillectomy or mandibulectomy surgical procedure for the treatment o...
Detailed Description
BACKGROUND: Head and neck lymphedema (HNL) is a common and sometimes debilitating complication of head and neck cancer (HNC) treatment. It occurs when the lymphatic system is either overloaded or dam...
Eligibility Criteria
Inclusion
- Adults (18 years of age or older)
- Any head and neck cancer patient undergoing laryngectomy, neck dissection, maxillectomy or mandibulectomy
- Inpatient and referred for HNL treatment following surgery
- Patients with previous chemoradiation therapy or head and neck surgery accepted
Exclusion
- Patients under the age of 18 years of age
- Patients who undergo neck dissection surgery that do not present with symptoms of HNL
- Patients with free tissue transfer reconstruction
- Unwilling or unable to consent
Key Trial Info
Start Date :
January 24 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2021
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT04045860
Start Date
January 24 2019
End Date
June 30 2021
Last Update
September 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Our Lady of the Lake Hospital
Baton Rouge, Louisiana, United States, 70808